Compare AU
Compare VBTC vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are VBTC and DRUG. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
VBTC | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 175 | 63 |
Median incremental investment | $1,096.75 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,851.56 | $1,875.72 |
Average age group | > 35 | 26 - 35 |
Key Summary
VBTC | DRUG | |
|---|---|---|
Strategy | VBTC.AX was created on 2024-06-18 by VanEck. The fund's investment portfolio concentrates primarily on long btc, short usd currency. The fund aims to provide a return that tracks the performance of the price of Bitcoin, before fees and other costs. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | VanEck Bitcoin ETF (100 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | |
Management fee | 0.59 % | 0.57 % |
Key Summary
VBTC | DRUG | |
|---|---|---|
Issuer | VanEck | BetaShares |
Tracking index | MarketVector Bitcoin Benchmark Rate - USD - Benchmark TR Net | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.59 % | 0.57 % |
Price | $32.04 | $8.12 |
Size | $186.268 million | $191.120 million |
10Y return | N/A | N/A |
Annual dividend/ distribution yield (5Y) | - % | 1.90 % |
Market | ASX | ASX |
First listed date | 19/06/2024 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
VBTC | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 175 | 63 |
Median incremental investment | $1,096.75 | $967.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,851.56 | $1,875.72 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
VBTC | DRUG | |
|---|---|---|
Pros |
| |
Cons |
|
VBTC | DRUG |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |